Targeting insulin-like growth factor pathways
Open Access
- 31 January 2006
- journal article
- review article
- Published by Springer Nature in British Journal of Cancer
- Vol. 94 (4) , 465-468
- https://doi.org/10.1038/sj.bjc.6602963
Abstract
No abstract availableKeywords
This publication has 48 references indexed in Scilit:
- Nordihydroguaiaretic Acid (NDGA) Inhibits the IGF-1 and c-erbB2/HER2/neu Receptors and Suppresses Growth in Breast Cancer CellsBreast Cancer Research and Treatment, 2005
- Trastuzumab after Adjuvant Chemotherapy in HER2-Positive Breast CancerNew England Journal of Medicine, 2005
- Inhibition of insulin-like growth factor-I receptor (IGF-IR) signaling and tumor cell growth by a fully human neutralizing anti–IGF-IR antibodyMolecular Cancer Therapeutics, 2005
- Neoadjuvant Trastuzumab Induces Apoptosis in Primary Breast CancersJournal of Clinical Oncology, 2005
- Involvement of Insulin Receptor Substrate 2 in Mammary Tumor MetastasisMolecular and Cellular Biology, 2004
- A recombinant humanized anti‐insulin‐like growth factor receptor type I antibody (h7C10) enhances the antitumor activity of vinorelbine and anti‐epidermal growth factor receptor therapy against human cancer xenograftsInternational Journal of Cancer, 2004
- Insulin-like growth factors and neoplasiaNature Reviews Cancer, 2004
- The Insulin-like Growth Factor System in Hematopoietic CellsLeukemia & Lymphoma, 2002
- Antitumor activity of the growth hormone receptor antagonist pegvisomant against human meningiomas in nude miceJournal of Neurosurgery, 2001
- Insulin receptor activation by IGF-II in breast cancers: evidence for a new autocrine/paracrine mechanismOncogene, 1999